Abstract
Topical acyclovir has been compared with topical steroids in a coded controlled trial of the treatment of keratouveitis caused by herpes zoster in 40 patients. Topical acyclovir was significantly superior to topical steroids in terms of treatment duration (75 days to 280 days), with no recurrences after the patients were weaned off treatment; there was a 63% recurrence rate in the steroid group. Corneal epithelial disease resolved significantly quicker in the acyclovir treated group. If recurrences occurred in the steroid group, other parts of the eye not initially affected were also involved. Treatment of such recurrences was more difficult than treatment of the initial attack.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bean B., Braun C., Balfour H. H., Jr Acyclovir therapy for acute herpes zoster. Lancet. 1982 Jul 17;2(8290):118–121. doi: 10.1016/s0140-6736(82)91090-x. [DOI] [PubMed] [Google Scholar]
- Gilbert G. J. Herpes zoster ophthalmicus and delayed contralateral hemiparesis. Relationship of the syndrome to central nervous system granulomatous angiitis. JAMA. 1974 Jul 15;229(3):302–304. [PubMed] [Google Scholar]
- Hayashi K., Uchida Y., Oshima M. Fluorescent antibody study of herpes zoster keratitis. Am J Ophthalmol. 1973 May;75(5):795–798. doi: 10.1016/0002-9394(73)90885-4. [DOI] [PubMed] [Google Scholar]
- Linnemann C. C., Jr, Alvira M. M. Pathogenesis of varicella-zoster angiitis in the CNS. Arch Neurol. 1980 Apr;37(4):239–240. doi: 10.1001/archneur.1980.00500530077013. [DOI] [PubMed] [Google Scholar]
- Marsh R. J., Easty D. L., Jones B. R. Iritis and iris atrophy in Herpes zoster ophthalmicus. Am J Ophthalmol. 1974 Aug;78(2):255–261. doi: 10.1016/0002-9394(74)90086-5. [DOI] [PubMed] [Google Scholar]
- Marsh R. J., Fraunfelder F. T., McGill J. I. Herpetic corneal epithelial disease. Arch Ophthalmol. 1976 Nov;94(11):1899–1902. doi: 10.1001/archopht.1976.03910040609004. [DOI] [PubMed] [Google Scholar]
- McGill J. Topical acyclovir in herpes zoster ocular involvement. Br J Ophthalmol. 1981 Aug;65(8):542–545. doi: 10.1136/bjo.65.8.542. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Merigan T. C., Rand K. H., Pollard R. B., Abdallah P. S., Jordan G. W., Fried R. P. Human leukocyte interferon for the treatment of herpes zoster in patients with cancer. N Engl J Med. 1978 May 4;298(18):981–987. doi: 10.1056/NEJM197805042981801. [DOI] [PubMed] [Google Scholar]
- Naumann G., Gass J. D., Font R. L. Histopathology of herpes zoster ophthalmicus. Am J Ophthalmol. 1968 Apr;65(4):533–541. doi: 10.1016/0002-9394(68)93869-5. [DOI] [PubMed] [Google Scholar]
- Pavan-Langston D., McCulley J. P. Herpes zoster dendritic keratitis. Arch Ophthalmol. 1973 Jan;89(1):25–29. doi: 10.1001/archopht.1973.01000040027007. [DOI] [PubMed] [Google Scholar]
- Peterslund N. A., Seyer-Hansen K., Ipsen J., Esmann V., Schonheyder H., Juhl H. Acyclovir in herpes zoster. Lancet. 1981 Oct 17;2(8251):827–830. doi: 10.1016/s0140-6736(81)91102-8. [DOI] [PubMed] [Google Scholar]
- Schwartz J. N., Cashwell F., Hawkins H. K., Klintworth G. K. Necrotizing retinopathy with herpes zoster ophthalmicus: a light and electron microscopical study. Arch Pathol Lab Med. 1976 Jul;100(7):386–391. [PubMed] [Google Scholar]
- Stevens D. A., Merigan T. C. Interferon, antibody, and other host factors in herpes zoster. J Clin Invest. 1972 May;51(5):1170–1178. doi: 10.1172/JCI106910. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Womack L. W., Liesegang T. J. Complications of herpes zoster ophthalmicus. Arch Ophthalmol. 1983 Jan;101(1):42–45. doi: 10.1001/archopht.1983.01040010044004. [DOI] [PubMed] [Google Scholar]